Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial

Luis G. Paz-Ares, MD, Phd provides an overview of his presentation at ASCO 2019 entitled Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent... Author: PharmaMar Added: 06/01/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts